# Weight Method — Complete Reference

> Telehealth weight-management programs. Licensed providers issue patient-specific prescriptions for compounded semaglutide ($205/month monthly, or from $139/month effective on the prepaid 12-month plan) and compounded tirzepatide ($329/month monthly, or from $225/month effective on the prepaid 12-month plan), dispensed by U.S.-licensed 503A compounding pharmacies. Compounded medications are not FDA-approved.

Weight Method is a telehealth weight-management company. Licensed healthcare providers issue patient-specific prescriptions for compounded semaglutide or compounded tirzepatide, which are dispensed by U.S.-licensed 503A compounding pharmacies. Weight Method does not dispense or prescribe brand-name Ozempic®, Wegovy®, Mounjaro®, or Zepbound® (the FDA-approved brand-name products manufactured by Novo Nordisk and Eli Lilly). Compounded medications are not FDA-approved; the FDA has not reviewed them for safety, efficacy, or manufacturing quality. Patients complete an online medical assessment, get reviewed by a licensed provider, and receive medication shipped to their door.

- Website: https://weightmethod.com
- Sister site: https://tupesoideal.com (Tu Peso Ideal — Spanish version)
- Service area: Florida (telehealth); expanding state by state as providers are licensed
- Languages: English and Spanish

---

## Company Overview

### What We Offer
- Online weight-management evaluations with licensed providers
- Patient-specific prescriptions for compounded semaglutide or compounded tirzepatide
- Medication dispensed and shipped by U.S.-licensed 503A compounding pharmacies
- Ongoing provider access and dosage management
- Patient portal for treatment tracking
- Weight Method does NOT dispense or prescribe brand-name Ozempic®, Wegovy®, Mounjaro®, or Zepbound® (those are the FDA-approved brand-name products manufactured by Novo Nordisk and Eli Lilly)
- Compounded medications dispensed by Weight Method's pharmacy partners are not FDA-approved

### Pricing
| Plan | Semaglutide | Tirzepatide | Type |
|------|------------|-------------|------|
| Monthly | $205/month | $329/month | Subscription (auto-renews monthly) |
| 3-month | $185/month | $296/month | Subscription (12-week commit, $50 activation on first invoice) |
| 12-month | from $139/month effective | from $225/month effective | Prepaid — one upfront payment, no auto-renewal |

All plans include: medication, provider review, shipping, and ongoing support. Promotion codes accepted at checkout.

### Eligibility Requirements
- Age: 18–100 years
- BMI ≥ 30 (obese) — eligible
- BMI ≥ 27 with comorbidities (diabetes, heart conditions) — eligible
- BMI < 27 without comorbidities — not eligible
- Tirzepatide recommended for BMI ≥ 35; semaglutide for BMI 27–34

---

## Patient Flow

### Step 1: Medical Assessment
Free online questionnaire at https://weightmethod.com/en/quiz collecting:
- Goal weight
- Current height and weight (BMI calculated server-side)
- Age
- Health history: diabetes, heart conditions, current medications, prior GLP-1 use
- Contact information and state of residence
- Medication preference (semaglutide or tirzepatide)

### Step 2: Pricing & Checkout
- Patient selects plan duration (monthly, 3-month, or prepaid 12-month)
- Checkout via Stripe with promotion code support
- Payment processed securely

### Step 3: Shipping
- Patient provides shipping address
- Medications shipped from US pharmacies

### Step 4: Medical Consent
Four consent forms signed electronically:
- Telehealth informed consent
- Medication-specific consent (semaglutide or tirzepatide)
- HIPAA authorization
- Terms of service agreement

### Step 5: Provider Review
- Board-certified provider reviews medical history
- Prescription approved or denied with clinical reasoning
- If approved: order created, medication prepared for shipment

### Step 6: Fulfillment
Order status progression: pending → processing → shipped → delivered
- Tracking numbers provided for FedEx shipments
- Subscription renewals handled automatically

### Step 7: Ongoing Care
- Patient portal for treatment management
- Order tracking and history
- Consent document access
- Profile management

---

## Medications

### Semaglutide (active pharmaceutical ingredient)
- **Class:** GLP-1 receptor agonist
- **Mechanism:** Mimics GLP-1 hormone, reduces appetite, slows gastric emptying
- **Administration:** Weekly subcutaneous injection
- **FDA-approved brand-name products containing semaglutide:** Wegovy® (chronic weight management) and Ozempic® (type 2 diabetes), both manufactured by Novo Nordisk; plus Rybelsus® (oral, type 2 diabetes) and Oral Wegovy® (oral, weight management)
- **Common side effects (per FDA labeling of brand-name products):** Nausea, vomiting, diarrhea, constipation, abdominal pain
- **Titration:** Per FDA labeling of brand-name Wegovy, start low, increase gradually over 16-20 weeks to maintenance dose
- **Contraindications (per FDA labeling):** Personal/family history of medullary thyroid carcinoma, MEN2 syndrome
- **Weight Method:** does NOT dispense brand-name Ozempic® or Wegovy®. Issues patient-specific prescriptions for compounded semaglutide dispensed by U.S.-licensed 503A pharmacies. Compounded semaglutide is not FDA-approved.
- **More info:** https://weightmethod.com/en/medications/semaglutide

### Tirzepatide (active pharmaceutical ingredient)
- **Class:** Dual GIP/GLP-1 receptor agonist
- **Mechanism:** Activates both GIP and GLP-1 receptors
- **Administration:** Weekly subcutaneous injection
- **FDA-approved brand-name products containing tirzepatide:** Zepbound® (chronic weight management) and Mounjaro® (type 2 diabetes), both manufactured by Eli Lilly
- **Common side effects (per FDA labeling of brand-name products):** Nausea, diarrhea, decreased appetite, vomiting, constipation
- **Titration:** Per FDA labeling of brand-name Zepbound, start at 2.5mg, increase every 4 weeks to maintenance dose
- **Contraindications (per FDA labeling):** Personal/family history of medullary thyroid carcinoma, MEN2 syndrome
- **Weight Method:** does NOT dispense brand-name Mounjaro® or Zepbound®. Issues patient-specific prescriptions for compounded tirzepatide dispensed by U.S.-licensed 503A pharmacies. Compounded tirzepatide is not FDA-approved.
- **More info:** https://weightmethod.com/en/medications/tirzepatide

### Semaglutide vs Tirzepatide
| Factor | Semaglutide | Tirzepatide |
|--------|------------|-------------|
| Mechanism | GLP-1 receptor agonist | Dual GIP + GLP-1 receptor agonist |
| FDA-approved brand-name products | Ozempic® (diabetes), Wegovy® (weight management) — Novo Nordisk | Mounjaro® (diabetes), Zepbound® (weight management) — Eli Lilly |
| Injection frequency | Weekly | Weekly |
| Weight Method compounded program (not FDA-approved) | $205/month monthly (from $139/mo effective on the prepaid 12-month plan) | $329/month monthly (from $225/mo effective on the prepaid 12-month plan) |

---

## Health Conditions Treated

### Obesity (BMI ≥ 30)
GLP-1 medications are FDA-approved for chronic weight management in adults with BMI ≥ 30. Clinical trials show sustained weight loss of 15-22% over 68-72 weeks.

### Overweight with Comorbidities (BMI ≥ 27)
Eligible when accompanied by: type 2 diabetes, cardiovascular disease, hypertension, dyslipidemia, or obstructive sleep apnea.

### Type 2 Diabetes
Semaglutide and tirzepatide are also used for glycemic control in type 2 diabetes under separate FDA-approved brand-name products that Weight Method does not dispense or prescribe.

### PCOS (Polycystic Ovary Syndrome)
GLP-1 medications show promise for PCOS-related weight management and insulin resistance improvement, though not FDA-approved specifically for PCOS.

### Cardiovascular Risk Reduction
Semaglutide (SELECT trial) demonstrated 20% reduction in major adverse cardiovascular events in overweight/obese adults without diabetes.

---

## Insurance & Cost

### Weight Method Compounded Program Pricing
Compounded semaglutide is $205/month monthly, or from $139/month effective on the prepaid 12-month plan; compounded tirzepatide is $329/month monthly, or from $225/month effective on the prepaid 12-month plan. The 3-month subscription lowers the monthly rate ($185 semaglutide / $296 tirzepatide) and carries a $50 activation fee on the first invoice. The 12-month plan is a single upfront payment — no auto-renewal. Compounded medications are not FDA-approved.

### Insurance Coverage
Coverage varies significantly by carrier, plan type, and state:
- **Blue Cross Blue Shield:** Variable by state; prior authorization typically required
- **Aetna:** Covers for BMI ≥ 30 or ≥ 27 with comorbidities; step therapy may apply
- **Cigna:** Commercial plans may cover; Medicare Advantage varies
- **UnitedHealthcare:** Prior authorization required; covers with documented medical necessity
- **Anthem:** Coverage depends on plan; employer-sponsored plans more likely to cover
- **Humana:** Medicare Advantage plans expanding coverage
- **Kaiser Permanente:** Integrated model; coverage varies by region

### Medicare & Medicaid
- Medicare Part D does not cover GLP-1s for weight loss (covers for diabetes only)
- Medicaid coverage varies by state; some states cover for obesity
- Legislative changes possible under the TREAT Act

---

## Content Library

### Educational Guides (https://weightmethod.com/en/guides)
50+ bilingual guides covering:
- GLP-1 medication science and mechanisms
- Weight loss nutrition and lifestyle guidance
- Treatment expectations and timelines
- Managing side effects
- Exercise with GLP-1 medications
- Mental health and weight management

### Blog (https://weightmethod.com/en/blog)
Regularly updated articles on:
- Latest GLP-1 research and FDA updates
- Patient stories and experiences
- Medication comparisons and analysis
- Cost and insurance updates
- Nutrition and lifestyle advice

### Telehealth Information (https://weightmethod.com/en/telehealth)
Guides on virtual healthcare:
- How online GLP-1 prescriptions work
- Telehealth safety and regulations
- State-by-state telehealth availability
- Virtual consultation process

### Dosage Resources
- Interactive dosage calculators for semaglutide and tirzepatide
- Titration schedules and timelines
- Syringe visual guides and concentration references

---

## Location Coverage

Weight Method provides telehealth weight-loss care to patients in the states where its licensed providers can prescribe (currently Florida; expanding state by state as providers are onboarded). Educational, city-specific information is available for 3,161+ cities with population ≥ 10,000.

Browse by state: https://weightmethod.com/en/weight-loss-clinic/state/[state]
Browse by city: https://weightmethod.com/en/weight-loss-clinic/[city]

---

## Active-Ingredient Comparison

- [Semaglutide vs Tirzepatide](https://weightmethod.com/en/compare/semaglutide-vs-tirzepatide): Mechanism, FDA-approved brand-name products, brand-trial outcomes

---

## Frequently Asked Questions

**What is Weight Method?**
Weight Method is a telehealth weight-management company. Licensed providers issue patient-specific prescriptions for compounded semaglutide or compounded tirzepatide, dispensed by U.S.-licensed 503A compounding pharmacies. Weight Method does not dispense or prescribe brand-name Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. Compounded medications are not FDA-approved.

**How much does it cost?**
The compounded semaglutide program is $205/month monthly (or from $139/month effective on the prepaid 12-month plan); the compounded tirzepatide program is $329/month monthly (or from $225/month effective on the prepaid 12-month plan). The 3-month plan is billed monthly at a lower rate ($185 / $296) with a $50 activation fee on the first invoice; the 12-month plan is a single upfront payment with no auto-renewal. Compounded medications are not FDA-approved.

**Do I need insurance?**
No. Weight Method's compounded program is cash-pay and does not run through insurance. HSA/FSA funds may be used.

**How do I qualify?**
You must be 18+ years old with a BMI ≥ 30, or BMI ≥ 27 with a qualifying health condition (diabetes, heart disease, etc.).

**How long until I receive medication?**
After completing the assessment and payment, medical review typically takes 1-3 business days. Shipping takes 3-5 business days after approval.

**Is this safe?**
All prescriptions are reviewed by licensed healthcare providers. Compounded medications dispensed pursuant to Weight Method prescriptions are prepared by U.S.-licensed 503A compounding pharmacies and are not FDA-approved; the FDA has not reviewed them for safety, efficacy, or manufacturing quality.

**Can I cancel my subscription?**
Monthly and 3-month plans are subscriptions: the monthly plan can be cancelled anytime, and the 3-month plan has a 12-week minimum commitment, then continues monthly until cancelled. The 12-month plan is a single prepaid payment with no auto-renewal — there is no recurring charge to cancel.

**Do you ship to my state?**
Weight Method currently provides telehealth care to patients in Florida and is expanding state by state. Take the quiz and we'll let you know as soon as we serve your state.

**What if I'm not approved?**
If our provider determines GLP-1 medication is not appropriate for you, you will be notified with an explanation. No charge is made until after assessment.

---

## Contact & Legal

- Email: support@weightmethod.com
- Privacy Policy: https://weightmethod.com/en/privacy
- Terms of Service: https://weightmethod.com/en/terms

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication. Weight Method prescriptions require medical review and approval by a licensed provider.